January/February 2025

Editor's Page

Hand Hygiene and Other Truths

Arsham Sheybani, MD

IGC Spotlight

Spotlight on the 2024 IGC

Updates from the annual Interventional Glaucoma Consortium.

Feature

The Worried Well

The overdiagnosis and overtreatment of glaucoma are growing concerns.

James D. Brandt, MD

Case Files

A Leaky Situation

The Seidel test of a bleb in an eye with advanced glaucoma is positive.

Jacob Brubaker, MD; Austin Bohner, MD; Craig Chaya, MD; Peter T. Chang, MD; Constance Okeke, MD, MSCE; and George R. Reiss, MD

The Literature

Glucagon-Like Peptide-1 Receptor Agonists

Studies evaluated the effects of these drugs on IOP and glaucoma.

Vivian L. Qin, MD, and Victoria L. Tseng, MD, PhD

Residents & Fellows

Private Practice Versus Academia

Weighing the potential pros and cons of two distinct career paths in ophthalmology.

Devang L. Bhoiwala, MD

Diagnostics

IOP Monitoring Via a Smartphone

A novel contact lens has the potential to transform glaucoma management.

Anna Huixin Zhang, MD, and Iqbal Ike K. Ahmed, MD, FRCSC

Global Perspectives

Bringing Ophthalmic Care to Nepal

Highlighting innovative efforts to further eye care in a remote setting.

Karen Chen, MD, MPhil, and Sunil Thakali, MD

Research Update

Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again)

A review of nicotinamide treatment for neuroprotection.

Flora Hui, PhD, and Pete A. Williams, PhD

Cover Focus

Introduction

Cover Focus

Selective Laser Trabeculoplasty as First-Line Therapy

Can this approach gain full acceptance over IOP-lowering drops?

Emily M. Schehlein, MD, and Brian M. Shafer, MD

Cover Focus

Phaco Plus MIGS

Common questions and considerations for a combined approach.

Ian Conner, MD, PhD, and Roma Patel, MD, MBA

Cover Focus

Alternative Bleb Procedures

Has a new gold standard emerged?

Peter T. Chang, MD, and Leon W. Herndon, MD

Cover Focus

Standalone MIGS

Weighing the benefits and risks of surgical approaches.

Nathan M. Radcliffe, MD

The Buzz on Eyetube

Seen & Heard